Page 3 - Julien Vignot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Julien vignot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Julien Vignot Today - Breaking & Trending Today

Vifor Pharma: First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease

Vamifeport (VIT-2763) is the first oral ferroportin inhibitor investigated for treatment of diseases with ineffective production of red blood cells and iron overload such as sickle cell disease ....

United States , United Kingdom , Vifor Pharma , Julien Vignot , Klaus Henning Jensen , Nathalie Ponnier , Swiss Stock Exchange , Drug Administration , Global Head Corporate Communications , Swiss Exchange , Vifor Pharma Group , European Medicines Agency , Fresenius Medical Care , Chief Medical Officer , Pharma Group , Vifor Fresenius Medical Care Renal Pharma , Head Corporate Communications , Investor Relations ,

Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee

Hervé Gisserot will join Vifor Pharma as Chief Commercial Officer on 17 January 2022 Responsibilities of Sales, Marketing and Market Access to be streamlined under Chief Commercial Officer ....

France General , Vifor Pharma , Julien Vignot , Abbas Hussain , Asia Pacific , Nathalie Ponnier , Institute Of Political Science Paris , Swiss Stock Exchange , Global Head Corporate Communications , Swiss Exchange , Vifor Pharma Executive Committee , Vifor Pharma Group , Fresenius Medical Care , Chief Commercial Officer , Market Access , Pharma Group , Senior Vice President , Political Science Paris , General Management , Regional Commercial Heads , Rare Disease , Chief Commercial , Chief Executive Officer , Vifor Fresenius Medical Care Renal Pharma , Head Corporate Communications , Investor Relations ,

Vifor Pharma Group: Vifor Pharma comments on market speculations

Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Due to current market speculations, Vifor Pharma Group states the following: Vifor Pharma Group systematically reviews options that ....

Vifor Pharma , Julien Vignot , Nathalie Ponnier , Swiss Stock Exchange , Vifor Pharma Group , Global Head Corporate Communications , Swiss Exchange , Fresenius Medical Care , Regulatory News , Pharma Group , Vifor Fresenius Medical Care Renal Pharma , Head Corporate Communications , Investor Relations ,

Vifor Pharma comments on market speculations

ST. GALLEN, Switzerland (BUSINESS WIRE) Regulatory News:AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LRDue to current market speculations, Vifor Pharma Group states the following:Vifor Pharma Group systematically reviews options that can strengthen its market position and/or accelerate the growth of the company both or. ....

Vifor Pharma , Julien Vignot , Nathalie Ponnier , Swiss Stock Exchange , Vifor Pharma Group , Global Head Corporate Communications , Swiss Exchange , Fresenius Medical Care , Regulatory News , Pharma Group , Vifor Fresenius Medical Care Renal Pharma , Investor Relations ,

Vifor Pharma announces changes to the Executive Committee as CFO retires

Colin Bond to retire as Chief Financial Officer of Vifor Pharma Group Succession recruitment ongoing Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group today ....

Colin Bond , Vifor Pharma , Julien Vignot , Abbas Hussain , Nathalie Ponnier , Swiss Stock Exchange , Vifor Pharma Group , Global Head Corporate Communications , Swiss Exchange , Fresenius Medical Care , Chief Financial Officer , Pharma Group , Chief Executive Officer , Vifor Fresenius Medical Care Renal Pharma , Head Corporate Communications , Investor Relations ,